RNS Number : 4073O
Hemogenyx Pharmaceuticals PLC
12 January 2026
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BQVXM815
Issuer Name
HEMOGENYX PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
David John Smith
City of registered office (if applicable)
Grimsby
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Name
City of registered office
Country of registered office
Interactive Investor Services Nominees Limited
Manchester
England
Transact Nominees Limited
London
England
HBP Systems Limited
Scunthorpe
England
Kamarin Computers Limited
Scunthorpe
England
HBP Monpellier Limited
Carlisle
England
Copier Systems Limited
Scunthorpe
England
GHC Property Services Limited
Grimsby
England
5. Date on which the threshold was crossed or reached
06-Jan-2026
6. Date on which Issuer notified
09-Jan-2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
7.762000
0.000000
7.762000
468923
Position of previous notification (if applicable)
6.750640
0.000000
6.750640
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB00BQVXM815
211976
256947
3.508800
4.253200
Sub Total 8.A
468923
7.762000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
David Smith
7.762000
7.762000%
David Smith
GHC Property Services Limited
2.414000
2.414000%
David Smith
HBP Systems Limited
0.459800
0.459800%
David Smith
Kamarin Computers Limited
0.459800
0.459800%
David Smith
HBP Monpellier Limited
0.459800
0.459800%
David Smith
Copier Systems Limited
0.459800
0.459800%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
09-Jan-2026
13. Place Of Completion
Hull, England
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUKUBRNVUARAR
